The 2025 targets include achieving around €62 billion in revenues, falling costs in absolute terms, a stable cost of risk, ...

Q1 2025 Earnings Conference Call April 3, 2025 9:00 AM ETCompany ParticipantsAlex Ng - VP-Corporate Development ...

Aker Horizons ASA (the "Company") hereby publishes its Annual Report 2024, which comprises the Board of Directors' Report including the Sustainability Statement, the consolidated accounts, parent ...

Chapel Down Group plc ( ($GB:CDGP) ) has provided an update. Chapel Down Group Plc announced that it will publish its annual ...

Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year ended December ...

Aegon Ltd. today publishes its Integrated Annual Report 2024. The report also reflects on the key trends that influence Aegon's businesses and its stakeholders, and how these trends impact the way in ...

This week’s Edmonds City Council meeting, while short on action items, was taken up with a series of reports providing ...

Copenhagen K Copenhagen, 26 March 2025 ANNOUNCEMENT no.10/2025 CEMAT A/SCompany reg. (CVR) no. 24 93 28 18Annual general meeting 2025 On 26 March 2025 at 1:00 pm the annual general meeting was held in ...

About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

today announced that an abstract highlighting data supporting the immune component of amezalpat’s purported mechanism of action has been accepted for poster presentation at the 2025 American ...

Annual Meeting of Shareholders Conference Call March 20, 2025 1:00 PM ET. Company Participants. James Gorman - Chairman of the Board Robert ...

Nagpur: Spelling errors, incorrect titles, and photos without captions or missing information came to the fore during the ...